Intrexon Raises $25M in Equity Financing | GenomeWeb

NEW YORK (GenomeWeb News) – Genetic engineering company Intrexon has raised $25 million in equity financing, according to a form filed this week with the SEC.

Intrexon, formerly known as Genomatix, is based in Blacksburg, Va., and uses modular DNA control systems to enhance capabilities, improve safety, and lower cost in human therapeutics, protein production, industrial enzymes, and agriculture, according to the company's website.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.